Seeking Alpha

MDVN
  Medivation, Inc. - NASDAQ

11/1/2014, 6:43 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
MDVN vs. ETF Alternatives
Company Description
Medivation, Inc. is a biopharmaceutical company engaged in the development of novel small molecule drugs to treat diseases like Alzheimer's disease and Huntington disease.
Sector: Healthcare
Industry: Biotechnology
Country: United States